We find ourselves in pandemic times. The global population is under siege by an infectious virus new to humankind. It’s called Severe Acute Respiratory Syndrome Coronavirus 2, or SARS-CoV-2. It’s the causative agent of the pandemic disease designated COVID-19. This viral adversary knows no politics. It recognizes no national boundaries. It is unconcerned with anyone’s identity. All 7.8 billion of us are the same to the virus: we are all hosts suitable to commandeer to make copies of itself.
DARPA has long recognized how devastating pandemic diseases like COVID-19 could be and the Agency embraced the attitude that it could do something about this threat. In recent years, the agency has been developing and supporting communities of innovators who are doing the science and applying the lessons they are learning to create a technology platform that stands a chance of this: preventing any outbreak of infectious disease—anywhere and anytime—from growing into a global conflagration like the one we are experiencing right now. In this new episode of the Voices from DARPA podcast, join a team of program managers in the agency’s Biological Technologies Office as they explain how they are striving to develop a multi-pronged technology platform that has the potential to render COVID-19 humanity’s last pandemic.
This latest episode of the Voices from DARPA podcast, as well as all of the others, are accessible from the DARPA website (https://www.darpa.mil/about-us/podcast).
Image Caption: Depiction of the structure of the new coronavirus, SARS-CoV-2, causative agent of the COVID-19 pandemic. (Graphic courtesy of the U.S. Centers for Disease Control and Prevention)
You are now leaving the DARPA.mil website that is under the control and
management of DARPA. The appearance of hyperlinks does not constitute
endorsement by DARPA of non-U.S. Government sites or the information,
products, or services contained therein. Although DARPA may or may not
use these sites as additional distribution channels for Department of
Defense information, it does not exercise editorial control over all of
the information that you may find at these locations. Such links are
provided consistent with the stated purpose of this website.
After reading this message, click to continue